Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Quarterly Distribution

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Quarterly Distribution

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–
Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA) and Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE) (the “Funds”) today announced important information concerning the Funds’ distributions declared in March 2023. This press release is issued as required by the Funds’ Managed Distribution Plan (the “Plan”) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make quarterly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the April distribution. It is not determinative of the tax character of the Funds’ distributions for the 2023 calendar year. Shareholders should note that the Funds’ total regular distribution amount is subject to change as a result of market conditions or other factors.

The amounts and sources of distributions reported in this notice are estimates, are not being provided for tax reporting purposes and the distribution may later be determined to be from other sources including realized short-term gains, long-term gains, to the extent permitted by law, and return of capital. The actual amounts and sources for tax reporting purposes will depend upon the Funds’ investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Distribution Period: First Quarter 2023, Payable April 17, 2023

Distribution Amount per Common Share (IGA): $0.197

Distribution Amount per Common Share (IDE): $0.229

The following table sets forth an estimate of the sources of the Fund’s April distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.

Voya Global Advantage and Premium Opportunity Fund

Source

 

Current

Distribution

 

% of Current

Distribution

 

Cumulative

Distributions for the

Fiscal Year-to-Date 

 

% of the Cumulative

Distributions for the

Fiscal Year-to-Date1 

Net Investment Income

 

$ 0.084

 

42.44%

 

$ 0.084

 

42.44%

Net Realized Short-Term Capital Gains

 

$ 0.043

 

21.84%

 

$ 0.043

 

21.84%

Net Realized Long-Term Capital Gains

 

$ 0.000

 

0.00%

 

$ 0.000

 

0.00%

Return of Capital or Other Capital Source(s)

 

$ 0.070

 

35.72%

 

$ 0.070

 

35.72%

Total per common share

 

$ 0.197

 

100.00%

 

$ 0.197

 

100.00%

Voya Infrastructure, Industrials and Materials Fund

Source

 

Current

Distribution

 

% of Current

Distribution

 

Cumulative

Distributions for the

Fiscal Year-to-Date

 

% of the Cumulative

Distributions for the

Fiscal Year-to-Date1

Net Investment Income

 

$ 0.066

 

28.95%

 

$ 0.066

 

28.95%

Net Realized Short-Term Capital Gains

 

$ 0.013

 

5.57%

 

$ 0.013

 

5.57%

Net Realized Long-Term Capital Gains

 

$ 0.000

 

0.00%

 

$ 0.000

 

0.00%

Return of Capital or Other Capital Source(s)

 

$ 0.150

 

65.49%

 

$ 0.150

 

65.49%

Total per common share

 

$ 0.229

 

100.00%

 

$ 0.229

 

100.00%

1 The Fund’s fiscal year is March 1, 2023 to February 28, 2024.

IMPORTANT DISCLOSURE: You should not draw any conclusions about the Funds’ investment performance from the amount of this distribution or from the terms of the Funds’ Plan. The Funds’ estimate that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Funds’ is paid back to you. A return of capital distribution does not necessarily reflect the Funds’ investment performance and should not be confused with ‘yield’ or ‘income.’ The amounts and sources of distributions reported in this Section 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Funds’ investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Funds’ will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Set forth in the tables below is information relating to the Fund’s performance based on its net asset value (NAV) for certain periods.

Voya Global Advantage and Premium Opportunity Fund

Average annual total return at NAV for the five year period ended on March 31, 20231

4.98%

Annualized current distribution rate expressed as a percentage of NAV as of March 31, 20232

7.92%

Cumulative total return at NAV for the fiscal year through March 31, 20233

-0.90%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of March 31, 20234

1.98%

Voya Infrastructure, Industrials and Materials Fund

Average annual total return at NAV for the five year period ended on March 31, 20231

2.84%

Annualized current distribution rate expressed as a percentage of NAV as of March 31, 20232

7.94%

Cumulative total return at NAV for the fiscal year through March 31, 20233

2.49%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of March 31, 20234

1.98%

1 Average annual total return at NAV represents the compound average of the annual NAV total returns of the Fund for the five-year period ended on March 31, 2023.

2 The annualized current distribution rate is the cumulative distribution rate annualized as a percentage of the Fund’s NAV as of March 31, 2023.

3 Cumulative total return at NAV is the percentage change in the Fund’s NAV for the period from the beginning of its fiscal year to March 31, 2023 including distributions paid and assuming reinvestment of those distributions.

4 Cumulative fiscal year distribution rate for the period from the year-to-date period as a percentage of the Fund’s NAV as of March 31, 2023.

Past performance is no guarantee of future results. The performance quoted represents past performance. Investment return and principal value of an investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Shares of closed-end funds often trade at a discount from their net asset value. The market price of Fund shares may vary from net asset value based on factors affecting the supply and demand for shares, such as Fund distribution rates relative to similar investments, investors’ expectations for future distribution changes, the clarity of the Fund’s investment strategy and future return expectations, and investors’ confidence in the underlying markets in which the Fund invests. Fund shares are subject to investment risk, including possible loss of principal invested. No Fund is a complete investment program and you may lose money investing in a Fund. An investment in a Fund may not be appropriate for all investors. Before investing, prospective investors should consider carefully the Fund’s investment objective, risks, charges and expenses.

Certain statements made on behalf of the Fund in this release are forward-looking statements. The Fund’s actual future results may differ significantly from those anticipated in any forward-looking statements due to numerous factors, including but not limited to a decline in value in equity markets in general or the Fund’s investments specifically. Neither the Fund nor Voya Investment Management undertake any responsibility to update publicly or revise any forward-looking statement.

This information should not be used as a basis for legal and/or tax advice. In any specific case, the parties involved should seek the guidance and advice of their own legal and tax counsel.

About Voya® Investment Management

Voya Investment Management manages approximately $317 billion in assets across public and private fixed income, equities, multi-asset solutions and alternative strategies for institutions, financial intermediaries and individual investors, drawing on a 50-year legacy of active investing and the expertise of 300+ investment professionals. Named a Best Place to Work in Money Management by Pensions & Investments for seven consecutive years, Voya IM has cultivated a culture grounded in a commitment to understanding and anticipating clients’ needs, producing strong investment performance, and embedding diversity, equity and inclusion in its business

SHAREHOLDER INQUIRIES: Shareholder Services at (800) 992-0180; voyainvestments.com

Kris Kagel, (800) 992-0180

KEYWORDS: Arizona United States North America

INDUSTRY KEYWORDS: Other Professional Services Asset Management Professional Services Finance

MEDIA:

Logo
Logo

BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site

BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site

LYNCHBURG, Va.–(BUSINESS WIRE)–
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington.

The DOE announced that the Hanford Integrated Tank Disposition Contract (ITDC) was awarded to Hanford Tank Waste Operations & Closure, LLC (H2C), which is a joint venture led by a BWXT subsidiary and includes subsidiaries of Amentum and Fluor.

“This is the largest single contract award in our company’s history and is a stair-step achievement as we strengthen our leadership position in environmental restoration at highly technical projects across the nation,” said Rex Geveden, BWXT’s president and chief executive officer. “Our company remains highly committed to this critical mission for the U.S. Department of Energy and our emphasis on environmental stewardship and sustainability more broadly going forward.”

“Our team is honored to take on the largest and most complex radioactive waste cleanup project in the United States,” said Heatherly Dukes, president of BWXT’s Technical Services Group. “We are committed to working with our DOE Environmental Management customer, regulatory authorities and the Tri-Cities community in safely reducing the environmental liabilities at the site in an efficient and effective manner that is protective of the workforce, the public and the environment.”

The scope of the ITDC includes operation of Hanford tank farm facilities, eventual operation of the Waste Treatment and Immobilization Plant, and responsibility for other core functions such as project management, security and emergency services, business performance, and environment, safety, health and quality.

The DOE is engaged in one of the great public works projects of this century at the Hanford Site near Richland, Washington. Responsible for the federal government’s cleanup of the legacy of more than 40 years of producing plutonium through the 1980s, DOE is transforming the site back into an operations mode to treat tank waste from the production era. More information is available from the DOE’s Office of Environmental Management.

Forward Looking Statements

BWXT cautions that this release contains forward-looking statements, including statements relating to the performance, timing, impact and value, to the extent contract value can be viewed as an indicator of future revenues, of the ITDC, future work at the Hanford site, or the award or exercise of any contract options or orders. These forward-looking statements involve a number of risks and uncertainties, including, among other things, modification or termination of the ITDC. If one or more of these or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, please see BWXT’s annual report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.

About BWXT

At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. Headquartered in Lynchburg, Virginia, BWXT is a Fortune 1000 and Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental remediation, nuclear medicine and space exploration. With approximately 7,000 employees, BWXT has 14 major operating sites in the U.S., Canada and the U.K. In addition, BWXT joint ventures provide management and operations at a dozen U.S. Department of Energy and NASA facilities. Follow us on Twitter at @BWXT and learn more at www.bwxt.com.

Media Contact

Jud Simmons

Senior Director, Media & Public Relations

434.522.6462 [email protected]

Investor Contact

Chase Jacobson

Vice President, Investor Relations

980.365.4300 [email protected]

KEYWORDS: Washington Virginia United States North America

INDUSTRY KEYWORDS: Other Energy Environment Environmental Issues Green Technology Energy Environmental Health Nuclear

MEDIA:

Logo
Logo

Lemonade To Announce First Quarter 2023 Financial Results

Lemonade To Announce First Quarter 2023 Financial Results

NEW YORK–(BUSINESS WIRE)–
Lemonade, Inc. (NYSE: LMND) today announced it will release its first quarter 2023 financial results on Wednesday, May 3, 2023 after market close. Lemonade will host a conference call the following day, Thursday, May 4, 2023 at 8:00 am Eastern time (5:00 am Pacific time) to discuss the results.

To register for this conference call, please use this link. Registrants will receive confirmation with dial-in details. Registrants may also dial in, toll-free, at 1 (888) 210-4149 or at +1 (646) 960-0145, conference ID 5819404.

In addition to the dial-in options, shareholders can participate by going to app.saytechnologies.com/lemonade-2023-q1 to submit questions to Say prior to the earnings call. The Q&A platform will be open for question submission starting April 27, 2023 at 8:00 am ET. Shareholders will be able to submit and upvote questions until May 3, 2023 at 7:00 pm ET. Shareholders can email [email protected] for any support inquiries.

A live webcast of the conference call will be available on the Lemonade Investor Relations website, investor.lemonade.com. Following the completion of the call, a replay will also be made available at investor.lemonade.com.

About Lemonade

Lemonade offers renters, homeowners, car, pet, and life insurance. Powered by artificial intelligence and social impact, Lemonade’s full stack insurance carriers in the US and the EU replace brokers and bureaucracy with bots and machine learning, aiming for zero paperwork and instant everything. A Certified B-Corp, Lemonade gives unused premiums to nonprofits selected by its community, during its annual Giveback. Lemonade is currently available in the United States, Germany, the Netherlands, France, and the UK, and continues to expand globally.

Follow @lemonade_inc on Twitter for updates.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including the date and time of the earnings call. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: Our history of losses and the fact that we may not achieve or maintain profitability in the future; our ability to retain and expand our customer base; the fact that the “Lemonade” brand may not become as widely known as incumbents’ brands or the brand may become tarnished; the denial of claims or our failure to accurately and timely pay claims; our ability to attain greater value from each user; the novelty of our business model and its unpredictable efficacy and susceptibility to unintended consequences; the possibility that we could be forced to modify or eliminate our Giveback, which could undermine our business model; the examinations and other targeted investigations by our primary and other state insurance regulators that could result in adverse examination findings and necessitate remedial actions; our limited operating history; our ability to manage our growth effectively; the impact of intense competition in the segments of the insurance industry in which we operate on our ability to attain or increase profitability; the unavailability of reinsurance at current levels and prices, which could limit our ability to write new business; our ability to renew reinsurance contracts on comparable duration and terms to those currently in effect; our exposure to counterparty risks as a result of reinsurance; the loss of personal customer information, damage to our reputation and brand, or harm to our business and operating results as a result of security incidents or real or perceived errors, failures or bugs in our systems, website or app; our actual or perceived failure to protect customer information and other data, respect customers’ privacy, or comply with data privacy and security laws and regulations; our ability to comply with extensive insurance industry regulations and the need to incur additional costs or devote additional resources to comply with changes to existing regulations; our exposure to additional regulatory requirements specific to other vertical markets that we enter or have entered, including auto, pet and life insurance, and the need to devote additional resources to comply with these regulations; the ability of Lemonade to successfully complete the integration of Metromile’s operations, product lines and technology; the ability of Lemonade to continue to implement its plans, forecasts and other expectations with respect to Metromile’s business and realize additional opportunities for growth and innovation; the ability of Lemonade to realize the anticipated synergies from the transaction in the anticipated amounts or within the anticipated timeframes or costs expectations or at all; the ability to maintain relationships with Lemonade’s and Metromile’s respective employees, customers, other business partners and governmental authorities; and our inability to predict the lasting impacts of COVID-19 to our business in particular, and the global economy generally. These and other important factors are discussed under the caption “Risk Factors” in our Form 10-K filed with the SEC on March 3, 2023, and in our other and subsequent filings with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s beliefs as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Yael Wissner-Levy

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Finance Business Professional Services Other Professional Services Insurance

MEDIA:

Logo
Logo

Spire Global Schedules First Quarter 2023 Results Conference Call

Spire Global Schedules First Quarter 2023 Results Conference Call

VIENNA, Va.–(BUSINESS WIRE)–Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a leading provider of space-based data, analytics and space services, announced today that it will hold a conference call with investors and analysts on Wednesday, May 10, 2023 at 5:00 p.m. ET to discuss the Company’s first quarter 2023 financial results. The news release announcing the first quarter 2023 results will be disseminated on May 10, 2023 after the market closes.

A live webcast of the conference call will be available on Spire Global’s Investor Relations website at https://ir.spire.com. The toll-free dial-in number for the live audio call beginning at 5:00 p.m. ET on May 10, 2023 is 877-841-2968. The international dial-in number for the live audio call is +1 201-689-8552. The conference ID for the call is 13738226. A replay of the call will be available via the web at https://ir.spire.com.

About Spire Global, Inc.

Spire (NYSE: SPIR) is a leading global provider of space-based data, analytics and space services, offering access to unique datasets and powerful insights about Earth from the ultimate vantage point so that organizations can make decisions with confidence, accuracy, and speed. Spire uses one of the world’s largest multipurpose satellite constellations to source hard to acquire, valuable data and enriches it with predictive solutions. Spire then provides this data as a subscription to organizations around the world so they can improve business operations, decrease their environmental footprint, deploy resources for growth and competitive advantage, and mitigate risk. Spire gives commercial and government organizations the competitive advantage they seek to innovate and solve some of the world’s toughest problems with insights from space. Spire has eight offices across the U.S., Canada, UK, Luxembourg and Singapore. To learn more, visit www.spire.com.

For Media:

Kristina Spychalski

Director of Communications

[email protected]

For Investors:

Benjamin Hackman

Head of Investor Relations

[email protected]

KEYWORDS: Virginia United States North America

INDUSTRY KEYWORDS: Technology Satellite Professional Services Aerospace Software Manufacturing Hardware Data Analytics Data Management Artificial Intelligence

MEDIA:

Logo
Logo

Enovix Announces Proposed $150 Million Offering of Convertible Senior Notes Due 2028

FREMONT, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (NASDAQ: ENVX), an advanced silicon battery company, today announced its intent to offer $150 million aggregate principal amount of Convertible Senior Notes due 2028 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Enovix also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $22.5 million aggregate principal amount of Notes. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Entities affiliated with Thurman J. Rodgers, Enovix’s Chairman (the “Affiliated Investors”), have indicated an interest in purchasing up to $5.0 million aggregate principal amount of additional Notes in a separate concurrent private placement under Section 4(a)(2) of the Securities Act (the Notes purchased by the Affiliated Investors, the “Affiliate Notes”). The Affiliate Notes are expected to be sold at the same price, and constitute part of the same series, as the Notes. The Affiliated Investors are under no obligation to purchase any of the Affiliate Notes offered and their interest in purchasing such Affiliate Notes is not a commitment to do so.

The Notes will be general unsecured obligations of Enovix and will accrue interest payable semiannually in arrears. The Notes will be convertible at the option of holders into cash, shares of Enovix’s common stock or a combination of cash and shares of Enovix’s common stock, at Enovix’s election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Offering.

Enovix expects to use a portion of the net proceeds from the Offering and the sale of the Affiliate Notes to pay the cost of the capped call transactions described below. Enovix expects to use the remaining net proceeds from the Offering and the sale of Affiliate Notes to build out a second battery cell manufacturing facility and fund the acquisition of production lines of its second generation (“Gen2”) manufacturing equipment, and for working capital and general corporate purposes. If the initial purchasers exercise their option to purchase additional Notes, Enovix expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions with the Option Counterparties (as defined below).

In connection with the pricing of the Notes, Enovix expects to enter into capped call transactions with one or more of the initial purchasers or affiliates thereof and/or other financial institutions (the “Option Counterparties”). The capped call transactions will cover, subject to customary adjustments, the number of shares of Enovix’s common stock initially underlying the Notes (including the Affiliate Notes). The capped call transactions are expected generally to reduce the potential dilution to Enovix’s common stock upon any conversion of Notes and/or offset any cash payments Enovix is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.

In connection with establishing their initial hedges of the capped call transactions, Enovix expects the Option Counterparties or their respective affiliates will enter into various derivative transactions with respect to Enovix’s common stock and/or purchase shares of Enovix’s common stock concurrently with or shortly after the pricing of the Notes, including with, or from, as the case may be, certain investors in the Notes. This activity could increase (or reduce the size of any decrease in) the market price of Enovix’s common stock or the trading price of the Notes at that time.

In addition, the Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Enovix’s common stock and/or purchasing or selling Enovix’s common stock or other securities of Enovix in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so during the 40 trading day period beginning on the 41st scheduled trading day prior to maturity of the Notes, or, to the extent Enovix exercises the relevant election under the capped call transactions, following any repurchase, redemption or conversion of the Notes). This activity could also cause or avoid an increase or a decrease in the market price of Enovix’s common stock or the Notes which could affect a noteholder’s ability to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, this could affect the number of shares, if any, and value of the consideration that a noteholder will receive upon conversion of its Notes.

The Notes and any shares of Enovix’s common stock potentially issuable upon conversion of the Notes have not been and will not be registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.

This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains forward-looking statements including statements concerning the proposed terms of the Notes and capped call transactions, the completion, timing and size of the proposed Offering of the Notes and sale of the Affiliate Notes and capped call transactions, the investors purchasing Notes and the amounts thereof, and the anticipated use of proceeds from the Offering and sale of the Affiliate Notes. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “seek,” “plan,” “project,” “target,” “looking ahead,” “look to,” “move into,” and similar expressions are intended to identify forward-looking statements. Forward-looking statements represent Enovix’s current beliefs, estimates and assumptions only as of the date of this press release and information contained in this press release should not be relied upon as representing Enovix’s estimates as of any subsequent date. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to market risks, trends and conditions. These risks are not exhaustive. Further information on these and other risks that could affect Enovix’s results is included in its filings with the Securities and Exchange Commission (“SEC”), including its Annual Report on Form 10-K for the fiscal year ended January 1, 2023, and the future reports that it may file from time to time with the SEC. Enovix assumes no obligation to, and does not currently intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

About Enovix

Enovix is on a mission to power the technologies of the future. Everything from IoT, mobile and computing devices, to the vehicle you drive, needs a better battery. The company’s disruptive architecture enables a battery with high energy density and capacity without compromising safety. Enovix is scaling its silicon-anode, lithium-ion battery manufacturing capabilities to meet customer demand.

For investor and media inquiries, please contact:

Enovix Corporation
Charles Anderson
Phone: +1 (612) 229-9729
Email: [email protected]

Or

The Blueshirt Group
Gary Dvorchak, CFA
Phone: (323) 240-5796
Email: [email protected]

For media inquiries, please contact:

Enovix Corporation
Kristin Atkins
Phone: +1 (650) 815-6934
Email: [email protected]

Source: Enovix Corporation



BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business Update

JERUSALEM, April 17, 2023 (GLOBE NEWSWIRE) — via InvestorWire — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today published its full-year financial results for the year ended December 31, 2022, and provided a business update. At the same time, the Company filed its Annual Report on Form 10-K with the Securities and Exchange Commission.

Business Update
& Recent Highlights

  • In late 2021 and early 2022, BiondVax signed definitive agreements with the Max Planck Society (MPG) and the University Medical Center Göttingen, Germany (UMG) aiming to enable BiondVax to build a pipeline of “bio-better” nanosized VHH antibodies (NanoAbs), which would exhibit significant advantages over currently approved human monoclonal antibodies (mAbs) for several therapeutic indications.
  • As compared to mAbs, the unique physicochemical characteristics of NanoAbs being generated by BiondVax’s scientific partners at the Max Planck Institute for Multidisciplinary Sciences (MPI-NAT) demonstrate several competitive attributes, such as greater binding affinity, target neutralization at lower drug concentrations, stability at high temperatures, convenient routes of administration and formulation advantages. The Company believes that if NanoAbs with these attributes are developed as drug candidates for specific indications where their attributes present an advantage over currently marketed mAbs, they would provide an opportunity to capture a meaningful share of several large and growing markets. At the same time, upfront costs and risks commonly associated with new drug development would be reduced (e.g., sparing the need to prove that neutralizing a specific target molecule with an antibody generates a beneficial clinical response in humans) and initiation of clinical development would be accelerated. In addition, having access to a multi-asset pipeline would hedge BiondVax’s risk and provide greater opportunity and flexibility in pursuing partnering deals with other pharma companies.
  • In addition to anti-SARS-CoV-2 NanoAbs for which BiondVax signed an exclusive worldwide licensing agreement with MPG, BiondVax has an exclusive option for an exclusive worldwide license agreement at pre-agreed financial terms for additional NanoAbs discovered and characterized under the BiondVax-MPG-UMG agreement. On September 20, 2022, BiondVax announced that it will focus on further NanoAb development beginning with NanoAbs targeting immune system cytokines such as IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis.
  • These new NanoAbs are in addition to BiondVax’s NanoAb program for the treatment and prophylactic prevention of COVID-19, for which the Company shared positive preclinical in vivo data indicating that the innovative inhaled anti-SARS-CoV-2 NanoAb virtually prevented illness when administered prophylactically. The results also demonstrated that when administered therapeutically, the inhaled NanoAb virtually eliminated the virus in lungs, and led to a significantly shorter and milder illness.
  • BiondVax is currently evaluating plans to commence a Phase 1/2a clinical trial while monitoring the ongoing evolution of the COVID-19 virus and variants of concern (“VoCs”) around the world. In the past few months major shifts in predominant VoCs have occurred rapidly and continuation of this pace could make it difficult to utilize the results of the Phase 1/2a trial in a subsequent pivotal trial in case the predominant VoC is different than the VoC predominant during the Phase 1/2a trial. Although, as previously communicated, BiondVax holds NanoAbs that cover all VoCs, MPI-NAT and UMG are working as part of the accompanying Research Collaboration with BiondVax on discovery and selection of a single NanoAb, aimed at neutralizing all current VoCs. Given the resources of the Company and the availability of additional NanoAbs targeting different indications to license from MPG and UMG, the Company deems it prudent to advance its pipeline while continuing to monitor the evolution of the COVID-19 virus.   
  • On December 6, 2022, BiondVax welcomed Professor Dr. med. Matthias Dobbelstein, Director of the Institute of Molecular Oncology at UMG and an Associate Member of the MPI-NAT, as a member of the Company’s Scientific Advisory Board (SAB).
  • BiondVax is offering its cGMP manufacturing capabilities to interested parties, including aseptic fill and finish suite, laboratories and experienced professionals for CDMO services. This may optimize use of BiondVax’s assets and generate revenues, while enabling the Company to prioritize its NanoAb pipeline development.
  • BiondVax began filing as a US domestic issuer in 2023. Consequently, the Company is now reporting in U.S. GAAP. Previously, as a foreign private issuer, the Company’s financial results were reported under IFRS GAAP.

“BiondVax’s recent achievements leave me very optimistic about BiondVax’s growth potential and ability to deliver value to our stakeholders,” commented Amir Reichman, BiondVax’s CEO. “In late 2021 and early 2022, we signed exclusive agreements with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, Germany to build a pipeline of ‘biobetter’ nanosized VHH antibodies (NanoAbs), which exhibit strong potential for several significant advantages over currently approved human monoclonal antibodies (mAbs), targeting diseases with attractive commercial opportunities. This past winter we published exciting data from the proof-of-concept in vivo trial of an inhaled NanoAb therapy. Looking forward, I’m excited to exercise our option to obtain an exclusive license at pre-agreed financial terms to anti-IL-17 NanoAbs targeting safe, effective, and convenient treatment of psoriatic lesions; scale up in-house NanoAb manufacturing; and conduct an in vitro proof-of-concept study and potentially also a preclinical trial of the IL-17 NanoAb as a therapy for psoriasis.”

“The BiondVax team, in collaboration with our scientific partners from MPI-NAT and UMG, has worked exceedingly hard to develop best in class capabilities in NanoAb technology-based drug development. I want to thank our shareholders for their continued support as we progress toward building the Company into a financial success by providing caregivers and patients with high-quality, innovative, de-risked pharmaceutical products that help protect and improve human life,” Reichman added.  

Full

Year 2022 Financial Summary

  • R&D expenses for 2022 amounted to $5.7 million compared with $3.2 million in 2021.
  • Marketing,
    general
    and administrative expenses for 2022 were $5.3 million compared with $7.6 million in 2021.
  • Financial
    income for 2022 was $5.2 million compared with $2.6 million for 2021. The increase in financial income was primarily due to currency exchange differences and the restructuring of the EIB loan, partially offset by the fair value of warrant liabilities.
  • Total operating expenses for 2022 were $11.06 million, compared with $10.8 million in 2021.
  • Net loss for 2022 was $5.8 million compared to a loss of $8.2 million for 2021.

As of December 31, 2022, BiondVax had cash and cash equivalents of $14 million as compared to $17.3 million as of December 31, 2021. The decrease in cash from December 31, 2021, to December 31, 2022, was primarily due to the operating expenses for 2022 offset by a public secondary offering of shares in December 2022, which resulted in gross proceeds of $8 million.

The complete audited financial results are available in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission. A summary is included in the tables below.

About BiondVax
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, the company has executed eight clinical trials including a seven-country, 12,400-participant Phase 3 trial of its vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline. www.biondvax.com.

Contact Details

Investor Relations | +972 8 930 2529 | ir@biondvax.com

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995. Words such as “expect,” “believe,” “intend,” “plan,” “continue,” “may,” “will,” “anticipate,” and similar expressions are intended to identify forward-looking statements. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future financial position, future revenue, projected expenses, prospects, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, statements regarding the timing of future
pre-clinical
clinical trials, and the therapeutic and commercial potential of NanoAbs. These forward-looking statements reflect management’s current views with respect to certain current and future events and are subject to various risks, uncertainties and assumptions that could cause the results to differ materially from those expected by the management of BiondVax Pharmaceuticals Ltd. Risks and uncertainties include, but are not limited to,
the risk that BiondVax may not be able to secure additional capital on attractive terms, if at all;
the risk that the therapeutic and commercial potential of NanoAbs will not be met; the risk of a delay in the preclinical and clinical
trials
data for NanoAbs, if any;
the risk that our business strategy may not be successful;
the risk that the European Investment Bank
(EIB)
may accelerate the loans under its finance contract with BiondVax; risks relating to the
SARS-CoV-2 (
COVID-19
)
virus
; BiondVax’s ability to acquire rights to additional product opportunities; BiondVax’s ability to enter into collaborations on terms acceptable to BiondVax or at all; timing of receipt of regulatory approval of BiondVax’s manufacturing facility in Jerusalem, if at all or when required; the risk that the manufacturing facility will not be able to be used for a wide variety of applications and other vaccine and treatment technologies
;
and the risk that drug development involves a lengthy and expensive process with uncertain outcomes. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s Annual Report on Form
10-K
filed with the Securities and Exchange Commission on
April
17
,
2023
.
BiondVax undertakes no obligation to revise or update any forward-looking statement for any reason.  

BALANCE SHEETS

U.S. dollars in
thousands (except share and per share data)

    December 31,
      2022       2021  
ASSETS        
         
CURRENT ASSETS:        
Cash and cash equivalents   $ 12,650     $ 17,241  
Short-term deposit     1,425       133  
Restricted short-term deposit     140       143  
Prepaid expenses and other receivables     155       326  
       
 
Total current assets     14,370       17,843  
         
NON-CURRENT ASSETS:        
Property, plant and equipment, net     11,245       12,386  
Operating lease right-of-use assets     1,452       1,807  
       
 
Total non-current assets     12,697       14,193  
         
Total assets   $ 27,067     $ 32,036  
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
         
CURRENT LIABILITIES:        
Trade payables   $ 716     $ 999  
Warrants     5,329        
Operating lease short-term liabilities     382       375  
Other payables     1,240       1,070  
         
Total current liabilities     7,667       2,444  
         
NON-CURRENT LIABILITIES:        
Loan from others     20,082       27,164  
Operating lease long-term liabilities     1,078       1,446  
         
Total non-current liabilities     21,160       28,610  
         
CONTINGENT LIABILITIES AND COMMITMENTS        
         
SHAREHOLDERS’ EQUITY:        
Ordinary shares of no par value: Authorized: 20,000,000,000 shares at December 31, 2022, and 1,800,000,000 at December 31, 2021; Issued 989,290,784 shares at December 31, 2022 and 739,048,544 shares at December 31, 2021.            
Additional paid-in capital     116,082       113,076  
Accumulated deficit     (115,835 )     (110,039 )
Other comprehensive loss     (2,007 )     (2,055 )
         
Total shareholders’ equity     (1,760 )     982  
         
Total liabilities and shareholders’ equity   $ 27,067     $ 32,036  
 

STATEMENTS OF COMPREHEN
SIVE LOSS

U.S. dollars in
thousands (except share and per share data)

  Year ended
  December 31,
    2022       2021  
       
Research and development $ 5,765     $ 3,249  
Marketing, general and administrative   5,296       7,625  
Other income         (12 )
       
Total operating loss   11,061       10,862  
       
Financial income, net   (5,265 )     (2,656 )
       
Net loss $ 5,796     $ 8,206  
       
Net loss per share attributable to ordinary shareholders, basic and diluted   (0.01 )     (0.02 )
       
Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted   754,076,407       564,575,967  
 

The notes in the Company’s financial report are an integral part of the financial statements. The complete financial results are available in the Form 10-K filed with the Securities and Exchange Commission (SEC).

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]



Guidewire Appoints Michael Howe as Chief Product Officer

Guidewire Appoints Michael Howe as Chief Product Officer

Enterprise software and insurance industry veteran brings 30 years of experience in insurance product strategy, innovation and portfolio expansion

SAN MATEO, Calif.–(BUSINESS WIRE)–Guidewire (NYSE: GWRE) is pleased to announce the appointment of Michael Howe as Chief Product Officer, reporting to Chief Executive Officer Mike Rosenbaum. In this new role, Howe will lead product strategy, product management, product marketing and the Guidewire partner marketplace. His organization will accelerate Guidewire’s application innovation roadmap driven by analytics, machine learning, and the generative artificial intelligence capabilities that Guidewire customers will require to effectively balance innovation and operational excellence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230417005814/en/

Michael Howe Appointed Chief Product Officer at Guidewire (Photo: Business Wire)

Michael Howe Appointed Chief Product Officer at Guidewire (Photo: Business Wire)

Howe is an accomplished senior executive with more than 30 years of experience in the enterprise software industry, with many years focused on the insurance industry. As Chief Product Officer at Applied Systems, Howe led all product-related functions and oversaw a broad expansion of the Applied product portfolio, strengthening flagship products, launching new products, and driving growth in new market segments across the insurance agent and broker channel. Prior to Applied, Howe held leadership roles in both public and private equity-backed enterprise software companies.

“I am thrilled to welcome Michael Howe to the Guidewire management team. His deep enterprise software experience and insurance domain knowledge will help us hone our product strategy and innovation velocity,” said Guidewire CEO Mike Rosenbaum. “There has never been a more exciting time for technology-driven innovation in the insurance industry and Michael’s experience and leadership will accelerate our ability to foster industry-wide transformation.”

“Guidewire is defining the future of innovation for the P&C insurance industry, which made joining the company as Chief Product Officer an exciting opportunity and an easy choice,” said Howe. “I look forward to working with our customers, partners, and the entire Guidewire team to realize a strategic product direction that leverages existing and emerging technologies within our platform, applications, and content to position our customers for continued growth.”

About Guidewire Software

Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. ​We combine digital, core, analytics, and machine learning to deliver our platform as a cloud service. More than 500 insurers in 38 countries, from new ventures to the largest and most complex in the world, run on Guidewire. As a partner to our customers, we continually evolve to enable their success. We are proud of our unparalleled implementation track record, with 1,000+ successful projects, supported by the largest R&D team and partner ecosystem in the industry. Our marketplace provides hundreds of applications that accelerate integration, localization, and innovation.

For more information, please visit www.guidewire.com and follow us on Twitter and LinkedIn.

NOTE: For information about Guidewire’s trademarks, visit https://www.guidewire.com/legal-notices.

Investor Contact:

Alex Hughes

Guidewire

(650) 356-4921

[email protected]

Media Contact:

Diana Stott, Director, Communications

Guidewire

(650) 781-9955

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Insurance Internet Data Management Professional Services Technology Apps/Applications Security

MEDIA:

Logo
Logo
Photo
Photo
Michael Howe Appointed Chief Product Officer at Guidewire (Photo: Business Wire)

Father-Son Duo Joins Ameriprise with $330 Million in Assets

Father-Son Duo Joins Ameriprise with $330 Million in Assets

Harry Slade III and Harry Slade IV joined Ameriprise for the flexibility to expand their practice and serve clients across multiple generations

MINNEAPOLIS–(BUSINESS WIRE)–
Father-son team Harry Slade III and Harry Slade IV recently joined the branch channel of Ameriprise Financial, Inc. (NYSE: AMP) serving multiple generations in Ellicott City, Md. Slade III, a 25-year industry veteran and Slade IV, who has served clients as an advisor for the past eight years, joined from Edward Jones and manage approximately $330 million in assets. The practice will operate as Ellicott Mills Wealth Management and is supported by client service associates Lynda Day, Stacy Fernen and Shawn Kramer.

“We’re a fourth-generation practice with deep roots in Ellicott City going back 125 years,” said Slade III. “At the same time, we’ve always had an eye on the future and wanted more control and flexibility in how we manage our business. Switching firms was not a decision we took lightly, but ultimately, Ameriprise was the right choice to support our vision. As the industry continues to evolve, we’re focused on growing our practice and creating a legacy that can best support our clients for years to come.”

The father and son duo are especially excited about the technology and financial planning capabilities provided by Ameriprise that are already helping them elevate their client offering. “We’re passionate about building lasting relationships with our clients, many of whom we’ve been working with for multiple generations,” said Slade IV. “We’re particularly excited about the opportunity to provide customized financial planning and advice for clients of all asset levels. The fully integrated technology suite at Ameriprise streamlines many of our day-to-day administrative tasks, freeing up our time to go deeper with clients and help them navigate the complexities within their financial situations – ultimately positioning us to provide a more tailored and impactful level of service.”

Ameriprise complex director Ed Eckenroad and branch manager Karen Burkhart support the team.

“We’re always looking to add quality advisors who are passionate about their work, and the clients and communities they serve – and that’s this father-and-son team to a tee,” said Burkhart. “By joining Ameriprise, they are able to work as true partners, which is key to serving their clients for years to come.”

As part of the transition, the Slade team will move into a new branch office in the Ellicott City area, which holds great significance to the Slade’s as they are avid outdoorsmen with a deep commitment to their community. Slade III is involved with the Kiwanis Club of Ellicott City and Farmers Feeding the Hungry. Slade IV is on the board of Friends of Patapsco Valley, a nonprofit organization focused on preservation of the valley’s natural resources.

Ameriprise has continued to attract experienced, productive financial advisors, with approximately 1,700 joining the firm in the last 5 years.1 Nine out of ten advisors who joined Ameriprise say the firm’s technology, financial planning capabilities and ability to acquire clients is better than their previous firm.2 To find out why experienced financial advisors are joining Ameriprise, visit ameriprise.com/why.

About Ameriprise Financial

At Ameriprise Financial, we have been helping people feel more confident about their financial future for more than 125 years. With extensive investment advice, asset management and insurance capabilities and a nationwide network of approximately 10,000 financial advisors3, we have the strength and expertise to serve the full range of individual and institutional investors’ financial needs.

Ameriprise Financial cannot guarantee future financial results.

Ameriprise Financial Services, LLC is an Equal Opportunity Employer.

Investment products are not insured by the FDIC, NCUA or any federal agency, are not deposits or obligations of, or guaranteed by any financial institution, and involve investment risks including possible loss of principal and fluctuation in value.

Investment advisory products and services are made available through Ameriprise Financial Services, LLC, a registered investment adviser.

Ameriprise Financial Services, LLC. Member FINRA and SIPC.

© 2023 Ameriprise Financial, Inc. All rights reserved.

1 Ameriprise Financial 2022 10-K.

2 Ameriprise asked experienced advisors who moved their book of business to the firm in the last one-to-five years to compare its support, resources, and capabilities to their previous firm and state their satisfaction with their experience. The survey results identified the top ways Ameriprise stands out compared to competitors. 294 advisors responded to the “Ultimate Advisor Partnership” survey, which was conducted in November 2021.

3 Ameriprise asked experienced advisors who moved their book of business to the firm in the last one-to-five years to compare its support, resources, and capabilities to their previous firm and state their satisfaction with their experience. The survey results identified the top ways Ameriprise stands out compared to competitors. 294 advisors responded to the “Ultimate Advisor Partnership” survey, which was conducted in November 2021.

Allison Harries, Media Relations

612.678.7035

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Finance Consulting Banking Professional Services Asset Management

MEDIA:

Logo
Logo

ServisFirst Bancshares, Inc. Announces Results For First Quarter of 2023

ServisFirst Bancshares, Inc. Announces Results For First Quarter of 2023

BIRMINGHAM, Ala.–(BUSINESS WIRE)–
ServisFirst Bancshares, Inc. (NYSE: SFBS), today announced earnings and operating results for the quarter ended March 31, 2023.

First Quarter 2023 Highlights:

  • Diluted earnings per share were $1.06 for the first quarter of 2023, unchanged from the first quarter of 2022. When adjusting for income on Paycheck Protection Program (“PPP”) loans in 2022, diluted earnings per share increased 7% over the first quarter of 2022. (1)
  • An increase of 23% in new accounts opened year-over-year.
  • Deposit balances grew $69 million during the first quarter of 2023 while the deposit pipeline increased by $244 million, or 51%.
  • Available liquidity sources totaled $8.4 billion as of March 31, 2023.
  • Return on assets increased from 1.53% to 1.63% year-over-year.
  • Book value per share grew from $21.61 to $24.63, or 14%, year-over-year.
  • No brokered deposits or FHLB borrowings as of March 31, 2023.
  • Bank level Tier 1 capital to average assets increased from 8.08% to 9.91% year-over-year.
  • Industry-leading credit quality measures.

Tom Broughton, Chairman, President and CEO, said, “Our business model has proven itself over the past 18 years and we continue to attract new customers with a 23% increase in new accounts opened year-over-year due to our financial stability, our commitment to customer service, and our team of responsive bankers.”

Bud Foshee, CFO, said, “We are pleased with a very good first quarter of growth in profitability, liquidity, and capital while maintaining pristine credit quality.”

(1) See “GAAP Reconciliation and Management Explanation of Non-GAAP Financial Measures” for a discussion of these Non-GAAP financial measures

FINANCIAL SUMMARY (UNAUDITED)

(In thousands except share and per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period Ending March 31, 2023

 

Period Ending December 31, 2022

 

% Change From Period Ending December 31, 2022 to Period Ending March 31, 2023

 

Period Ending March 31, 2022

 

% Change From Period Ending March 31, 2022 to Period Ending March 31, 2023

QUARTERLY OPERATING RESULTS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

$

57,971

 

 

$

67,724

 

 

(14)

%

 

$

57,613

 

 

1

%

Net Income Available to Common Stockholders

 

$

57,971

 

 

$

67,693

 

 

(14)

%

 

$

57,613

 

 

1

%

Diluted Earnings Per Share

 

$

1.06

 

 

$

1.24

 

 

(15)

%

 

$

1.06

 

 

%

Return on Average Assets

 

 

1.63

%

 

 

1.89

%

 

 

 

 

 

1.53

%

 

 

 

Return on Average Common Stockholders’ Equity

 

 

17.83

%

 

 

21.27

%

 

 

 

 

 

20.09

%

 

 

 

Average Diluted Shares Outstanding

 

 

54,534,482

 

 

 

54,537,685

 

 

 

 

 

 

54,522,042

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE SHEET

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

14,566,559

 

 

$

14,595,753

 

 

%

 

$

15,339,419

 

 

(5)

%

Loans

 

 

11,629,802

 

 

 

11,687,968

 

 

%

 

 

9,898,957

 

 

17

%

Non-interest-bearing Demand Deposits

 

 

2,898,736

 

 

 

3,321,347

 

 

(13)

%

 

 

4,889,495

 

 

(41)

%

Total Deposits

 

 

11,615,317

 

 

 

11,546,805

 

 

1

%

 

 

12,408,755

 

 

(6)

%

Stockholders’ Equity

 

 

1,339,817

 

 

 

1,297,896

 

 

3

%

 

 

1,172,975

 

 

14

%

DETAILED FINANCIALS

ServisFirst Bancshares, Inc. reported net income and net income available to common stockholders of $58.0 million for the quarter ended March 31, 2023, compared to net income and net income available to common stockholders of $57.6 million for the same quarter in 2022. Basic and diluted earnings per common share were $1.07 and $1.06, respectively, for the first quarter of 2023, compared to $1.06 for both in the first quarter of 2022.

Annualized return on average assets was 1.63% and annualized return on average common stockholders’ equity was 17.83% for the first quarter of 2023, compared to 1.53% and 20.09%, respectively, for the first quarter of 2022.

Net interest income was $108.3 million for the first quarter of 2023, compared to $122.4 million for the fourth quarter of 2022 and $105.7 million for the first quarter of 2022. The net interest margin in the first quarter of 2023 was 3.15% compared to 3.52% in the fourth quarter of 2022 and 2.89% in the first quarter of 2022. Loan yields were 5.70% during the first quarter of 2023 compared to 5.32% during the fourth quarter of 2022 and 4.29% during the first quarter of 2022. Investment yields were 2.54% during the first quarter of 2023, compared to 2.49% during the fourth quarter of 2022 and 2.17% during the first quarter of 2022. Average interest-bearing deposit rates were 2.68% during the first quarter of 2023, compared to 1.70% during the fourth quarter of 2022 and 0.31% during the first quarter of 2022. Average federal funds purchased rates were 4.67% during the first quarter of 2023, compared to 3.75% during the fourth quarter of 2022 and 0.23% during the first quarter of 2022.

Average loans for the first quarter of 2023 were $11.65 billion, an increase of $166.4 million, or 5.9% annualized, over average loans of $11.49 billion for the fourth quarter of 2022, and an increase of $2.00 billion, or 20.8%, over average loans of $9.65 billion for the first quarter of 2022.

Average total deposits for the first quarter of 2023 were $11.50 billion, an increase of $118.9 million, or 4.2%, annualized, over average total deposits of $11.39 billion for the fourth quarter of 2022, and a decrease of $875.0 million, or 7.1%, over average total deposits of $12.38 billion for the first quarter of 2022.

Non-performing assets to total assets were 0.12% for the first quarter of 2023, unchanged compared to 0.12% for the fourth quarter of 2022, and a decrease of two basis points compared to 0.14% for the first quarter of 2022. Annualized net charge-offs to average loans were 0.05% for the first quarter of 2023, compared to 0.06% and 0.11% for the fourth quarter of 2022 and first quarter of 2022, respectively. The allowance for credit losses as a percentage of total loans at March 31, 2023, December 31, 2022 and March 31, 2022, was 1.28%, 1.25%, and 1.21%, respectively. We recorded a $4.2 million provision for credit losses in the first quarter of 2023 compared to $7.1 million in the fourth quarter of 2022, and $5.4 million in the first quarter of 2022.

Non-interest income decreased $1.6 million, or 20.5%, to $6.3 million for the first quarter of 2023 from $7.9 million in the first quarter of 2022, and decreased $645,000, or 9.3%, on a linked quarter basis. Service charges on deposit accounts decreased $208,000, or 9.7%, to $1.9 million from the first quarter of 2022 to the first quarter of 2023, and increased $68,000, or 3.6%, on a linked quarter basis. Mortgage banking revenue decreased $84,000, or 16.0%, to $442,000 from the first quarter of 2022 to the first quarter of 2023, and decreased $72,000, or 14.0%, on a linked quarter basis. Net credit card revenue decreased $683,000, or 28.8%, to $1.7 million during the first quarter of 2023, compared to $2.4 million during the first quarter of 2022, and decreased $572,000, or 25.3%, on a linked quarter basis. The number of credit card accounts increased approximately 8.2% and the aggregate amount of spend on all credit card accounts increased 14.7% during the first quarter of 2023 compared to the first quarter of 2022. Cash surrender value life insurance increased $13,000, or 0.8%, to $1.6 million during the first quarter of 2023, compared to $1.6 million during the first quarter of 2022, and increased $21,000, or 1.3%, on a linked quarter basis. Other operating income for the first quarter of 2023 decreased $4.0 million, or 86.3%, to $635,000 from $4.6 million in the first quarter of 2022, and decreased $90,000, or 12.4%, on a linked quarter basis. Other income in the first quarter of 2022 included $3.4 million of income on our interest rate cap. We did not recognize any income on the cap during the first quarter of 2023 and $162,000 during the fourth quarter of 2022. Merchant service revenue increased by $118,000, or 35.2%, to $455,000, during the first quarter of 2023, from $336,000 during the first quarter of 2022, and decreased $35,000, or 7.2%, on a linked quarter basis.

Non-interest expense for the first quarter of 2023 increased $2.4 million, or 6.6%, to $39.7 million from $37.2 million in the first quarter of 2022, and increased $1.6 million, or 4.1%, on a linked quarter basis. Salary and benefit expense for the first quarter of 2023 increased $765,000, or 4.2%, to $19.1 million from $18.3 million in the first quarter of 2022, and decreased $164,000, or 0.9%, on a linked quarter basis. The number of FTE employees increased by 62 to 573 at March 31, 2023 compared to 511 at March 31, 2022, and increased by 2 from the end of the fourth quarter of 2022. Equipment and occupancy expense increased $502,000, or 17.1%, to $3.4 million in the first quarter of 2023, from $2.9 million in the first quarter of 2022, and increased $172,000, or 5.3% on a linked-quarter basis. Third party processing and other services expense increased $1.7 million, or 30.0%, to $7.3 million in the first quarter of 2023, from $5.6 million in the first quarter of 2022, and decreased $886,000, or 10.8%, on a linked-quarter basis. The increase year-over-year in third party processing also includes Federal Reserve Bank charges related to correspondent bank settlement activities. Professional services expense increased $662,000, or 66.7%, to $1.7 million in the first quarter of 2023, from $992,000 in the first quarter of 2022, and increased $732,000, or 79.4%, on a linked quarter basis. FDIC and other regulatory assessments increased $385,000, or 34.0%, to $1.5 million in the first quarter of 2023, from $1.1 million in the first quarter of 2022, and increased $206,000, or 15.7%, on a linked quarter basis. Other operating expenses for the first quarter of 2023 decreased $1.6 million, or 18.8%, to $6.7 million from $8.3 million in the first quarter of 2022, and increased $1.7 million on a linked-quarter basis. The efficiency ratio was 34.60% during the first quarter of 2023 compared to 32.74% during the first quarter of 2022 and compared to 29.45% during the fourth quarter of 2022.

Income tax expense decreased $687,000, or 5.1%, to $12.8 million in the first quarter of 2023, compared to $13.5 million in the first quarter of 2022. Our effective tax rate was 18.07% for the first quarter of 2023 compared to 18.96% for the first quarter of 2022. We recognized an aggregate of $3.9 million in credits during the first quarter of 2023 related to investments in tax credit partnerships, compared to an aggregate of $3.3 million in credits during the first quarter of 2022. We recognized a reduction in provision for income taxes resulting from excess tax benefits from the exercise and vesting of stock options and restricted stock during the first quarter of 2023 and 2022 of $1.1 million and $572,000, respectively.

GAAP Reconciliation and Management Explanation of Non-GAAP Financial Measures

We originated over 7,400 PPP loans with an aggregate balance of approximately $1.5 billion during the COVID-19 pandemic. At March 31, 2022, we had outstanding PPP loans of $107.6 million. Financial measures in this press release that are presented adjusted for our PPP activities are net income available to common stockholders and diluted earnings per share. These financial measures exclude the impact of PPP loans, net of tax, and are considered non-GAAP financial measures. We believe these non-GAAP financial measures provide useful information to management and investors that is supplementary to our financial condition, results of operations and cash flows computed in accordance with GAAP; however, we acknowledge that these non-GAAP financial measures have a number of limitations. As such, you should not view these disclosures as a substitute for results determined in accordance with GAAP, and they are not necessarily comparable to non-GAAP financial measures that other companies, including those in our industry, use. The following reconciliation table provides a more detailed analysis of the non-GAAP financial measures as of and for the comparative periods presented in this press release. Dollars are in thousands, except share and per share data.

 

 

 

 

Three Months Ended

March 31, 2022

Net income – GAAP

 

$

57,613

 

 

Adjustments:

 

 

 

 

PPP loan income

 

 

(4,869

)

 

 

Tax on adjustment

 

 

1,222

 

Adjusted net income – non-GAAP

 

$

53,966

 

 

 

 

 

 

 

Diluted earnings per share – GAAP

 

$

1.06

 

 

Adjustments:

 

 

 

 

PPP loan income

 

 

(0.09

)

 

 

Tax on adjustment

 

 

0.02

 

Adjusted diluted earnings per share – non-GAAP

 

$

0.99

 

About ServisFirst Bancshares, Inc.

ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Birmingham, Huntsville, Mobile, Montgomery and Dothan, Alabama, Northwest Florida, West Central Florida, Nashville, Tennessee, Atlanta, Georgia, Charleston, South Carolina, and Charlotte and Asheville, North Carolina.

ServisFirst Bancshares, Inc. files periodic reports with the U.S. Securities and Exchange Commission (SEC). Copies of its filings may be obtained through the SEC’s website at www.sec.gov or at www.servisfirstbancshares.com.

Statements in this press release that are not historical facts, including, but not limited to, statements concerning future operations, results or performance, are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933. The words “believe,” “expect,” “anticipate,” “project,” “plan,” “intend,” “will,” “could,” “would,” “might” and similar expressions often signify forward-looking statements. Such statements involve inherent risks and uncertainties. ServisFirst Bancshares, Inc. cautions that such forward-looking statements, wherever they occur in this press release or in other statements attributable to ServisFirst Bancshares, Inc., are necessarily estimates reflecting the judgment of ServisFirst Bancshares, Inc.’s senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. Such forward-looking statements should, therefore, be considered in light of various factors that could affect the accuracy of such forward-looking statements, including, but not limited to: the global health and economic crisis precipitated by the COVID-19 outbreak; general economic conditions, especially in the credit markets and in the Southeast; the performance of the capital markets; changes in interest rates, yield curves, interest rate spread relationships and inflation; changes in accounting and tax principles, policies or guidelines; changes in legislation or regulatory requirements; changes as a result of our reclassification as a large financial institution by the FDIC; changes in our loan portfolio and the deposit base; economic crisis and associated credit issues in industries most impacted by the COVID-19 outbreak; possible changes in laws and regulations and governmental monetary and fiscal policies, including, but not limited to, economic stimulus initiatives and the ability of the U.S. Congress to increase the U.S. statutory debt limit as needed; the cost and other effects of legal and administrative cases and similar contingencies; possible changes in the credit worthiness of customers and the possible impairment of the collectability of loans and the value of collateral; the effect of natural disasters, such as hurricanes and tornados, in our geographic markets; the effect of data breaches, cyberattacks or other data security issues; and increased competition from both banks and non-bank financial institutions. The foregoing list of factors is not exhaustive. For discussion of these and other risks that may cause actual results to differ from expectations, please refer to “Cautionary Note Regarding Forward-looking Statements” and “Risk Factors” in our most recent Annual Report on Form 10-K, and our other SEC filings. If one or more of the factors affecting our forward-looking information and statements proves incorrect, then our actual results, performance or achievements could differ materially from those expressed in, or implied by, forward-looking information and statements contained herein. Accordingly, you should not place undue reliance on any forward-looking statements, which speak only as of the date made. ServisFirst Bancshares, Inc. assumes no obligation to update or revise any forward-looking statements that are made from time to time.

More information about ServisFirst Bancshares, Inc. may be obtained over the Internet at www.servisfirstbancshares.com or by calling (205) 949-0302.

SELECTED FINANCIAL HIGHLIGHTS (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter 2023

 

4th Quarter 2022

 

3rd Quarter 2022

 

2nd Quarter 2022

 

1st Quarter 2022

CONSOLIDATED STATEMENT OF INCOME

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

181,322

 

 

$

170,273

 

 

$

149,299

 

 

$

126,555

 

 

$

113,188

 

Interest expense

 

 

73,021

 

 

 

47,889

 

 

 

22,881

 

 

 

10,187

 

 

 

7,466

 

Net interest income

 

 

108,301

 

 

 

122,384

 

 

 

126,418

 

 

 

116,368

 

 

 

105,722

 

Provision for credit losses

 

 

4,197

 

 

 

7,135

 

 

 

15,603

 

 

 

9,507

 

 

 

5,362

 

Net interest income after provision for credit losses

 

 

104,104

 

 

 

115,249

 

 

 

110,815

 

 

 

106,861

 

 

 

100,360

 

Non-interest income

 

 

6,321

 

 

 

6,966

 

 

 

8,939

 

 

 

9,506

 

 

 

7,948

 

Non-interest expense

 

 

39,664

 

 

 

38,092

 

 

 

42,685

 

 

 

39,821

 

 

 

37,218

 

Income before income tax

 

 

70,761

 

 

 

84,123

 

 

 

77,069

 

 

 

76,546

 

 

 

71,090

 

Provision for income tax

 

 

12,790

 

 

 

16,399

 

 

 

13,038

 

 

 

14,410

 

 

 

13,477

 

Net income

 

 

57,971

 

 

 

67,724

 

 

 

64,031

 

 

 

62,136

 

 

 

57,613

 

Preferred stock dividends

 

 

 

 

 

31

 

 

 

 

 

 

31

 

 

 

 

Net income available to common stockholders

 

$

57,971

 

 

$

67,693

 

 

$

64,031

 

 

$

62,105

 

 

$

57,613

 

Earnings per share – basic

 

$

1.07

 

 

$

1.25

 

 

$

1.18

 

 

$

1.14

 

 

$

1.06

 

Earnings per share – diluted

 

$

1.06

 

 

$

1.24

 

 

$

1.17

 

 

$

1.14

 

 

$

1.06

 

Average diluted shares outstanding

 

 

54,534,482

 

 

 

54,537,716

 

 

 

54,528,554

 

 

 

54,532,385

 

 

 

54,522,042

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED BALANCE SHEET DATA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

14,566,559

 

 

$

14,595,753

 

 

$

13,890,030

 

 

$

14,494,317

 

 

$

15,339,419

 

Loans

 

 

11,629,802

 

 

 

11,687,968

 

 

 

11,278,614

 

 

 

10,617,320

 

 

 

9,898,957

 

Debt securities

 

 

1,646,937

 

 

 

1,678,936

 

 

 

1,714,603

 

 

 

1,790,218

 

 

 

1,617,977

 

Non-interest-bearing demand deposits

 

 

2,898,736

 

 

 

3,321,347

 

 

 

3,661,936

 

 

 

4,686,511

 

 

 

4,889,495

 

Total deposits

 

 

11,615,317

 

 

 

11,546,805

 

 

 

11,051,915

 

 

 

11,772,337

 

 

 

12,408,755

 

Borrowings

 

 

65,417

 

 

 

64,726

 

 

 

64,721

 

 

 

64,716

 

 

 

64,711

 

Stockholders’ equity

 

 

1,339,817

 

 

 

1,297,896

 

 

 

1,242,589

 

 

 

1,211,918

 

 

 

1,172,975

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares outstanding

 

 

54,398,025

 

 

 

54,326,527

 

 

 

54,324,007

 

 

 

54,306,875

 

 

 

54,282,132

 

Book value per share

 

$

24.63

 

 

$

23.89

 

 

$

22.87

 

 

$

22.32

 

 

$

21.61

 

Tangible book value per share (1)

 

$

24.38

 

 

$

23.64

 

 

$

22.62

 

 

$

22.07

 

 

$

21.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SELECTED FINANCIAL RATIOS (Annualized)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest margin

 

 

3.15

%

 

 

3.52

%

 

 

3.64

%

 

 

3.26

%

 

 

2.89

%

Return on average assets

 

 

1.63

%

 

 

1.89

%

 

 

1.77

%

 

 

1.67

%

 

 

1.53

%

Return on average common stockholders’ equity

 

 

17.83

%

 

 

21.27

%

 

 

20.49

%

 

 

20.93

%

 

 

20.09

%

Efficiency ratio

 

 

34.60

%

 

 

29.45

%

 

 

31.54

%

 

 

31.64

%

 

 

32.74

%

Non-interest expense to average earning assets

 

 

1.15

%

 

 

1.10

%

 

 

1.23

%

 

 

1.11

%

 

 

1.02

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPITAL RATIOS (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common equity tier 1 capital to risk-weighted assets

 

 

10.01

%

 

 

9.54

%

 

 

9.37

%

 

 

9.59

%

 

 

9.86

%

Tier 1 capital to risk-weighted assets

 

 

10.02

%

 

 

9.54

%

 

 

9.37

%

 

 

9.59

%

 

 

9.87

%

Total capital to risk-weighted assets

 

 

11.54

%

 

 

11.06

%

 

 

10.91

%

 

 

11.12

%

 

 

11.43

%

Tier 1 capital to average assets

 

 

9.49

%

 

 

9.29

%

 

 

8.84

%

 

 

8.19

%

 

 

7.67

%

Tangible common equity to total tangible assets (1)

 

 

9.11

%

 

 

8.81

%

 

 

8.86

%

 

 

8.28

%

 

 

7.56

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) This press release also contains certain non-GAAP financial measures, including tangible common stockholders’ equity, total tangible assets, tangible book value per share and tangible common equity to total tangible assets, each of which excludes goodwill associated with our acquisition of Metro Bancshares, Inc. in January 2015.

(2) Regulatory capital ratios for most recent period are preliminary.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2023

 

March 31, 2022

 

% Change

ASSETS

 

 

 

 

 

 

 

 

 

Cash and due from banks

 

$

139,175

 

 

$

103,439

 

 

35

 

%

Interest-bearing balances due from depository institutions

 

 

725,318

 

 

 

3,315,312

 

 

(78

)

%

Federal funds sold

 

 

6,478

 

 

 

24,638

 

 

(74

)

%

 

Cash and cash equivalents

 

 

870,971

 

 

 

3,443,389

 

 

(75

)

%

Available for sale debt securities, at fair value

 

 

624,948

 

 

 

784,673

 

 

(20

)

%

Held to maturity debt securities (fair value of $937,960 at March 31, 2023 and $799,347 at March 31, 2022)

 

 

1,021,989

 

 

 

833,304

 

 

23

 

%

Restricted equity securities

 

 

7,307

 

 

 

7,734

 

 

(6

)

%

Mortgage loans held for sale

 

 

1,651

 

 

 

403

 

 

310

 

%

Loans

 

 

11,629,802

 

 

 

9,898,957

 

 

17

 

%

Less allowance for credit losses

 

 

(148,965

)

 

 

(119,463

)

 

25

 

%

 

Loans, net

 

 

11,480,837

 

 

 

9,779,494

 

 

17

 

%

Premises and equipment, net

 

 

60,093

 

 

 

59,908

 

 

 

%

Goodwill and other identifiable intangible assets

 

 

13,615

 

 

 

13,615

 

 

 

%

Other assets

 

 

485,148

 

 

 

416,899

 

 

16

 

%

 

Total assets

 

$

14,566,559

 

 

$

15,339,419

 

 

(5

)

%

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Deposits:

 

 

 

 

 

 

 

 

 

 

Non-interest-bearing

 

$

2,898,736

 

 

$

4,889,495

 

 

(41

)

%

 

Interest-bearing

 

 

8,716,581

 

 

 

7,519,260

 

 

16

 

%

 

 

Total deposits

 

 

11,615,317

 

 

 

12,408,755

 

 

(6

)

%

Federal funds purchased

 

 

1,480,160

 

 

 

1,639,238

 

 

(10

)

%

Other borrowings

 

 

65,417

 

 

 

64,711

 

 

1

 

%

Other liabilities

 

 

65,848

 

 

 

53,740

 

 

23

 

%

 

Total liabilities

 

 

13,226,742

 

 

 

14,166,444

 

 

(7

)

%

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

Preferred stock, par value $0.001 per share; 1,000,000 authorized and undesignated at March 31, 2023 and March 31, 2022

 

 

 

 

 

 

 

 

 

 

Common stock, par value $0.001 per share; 200,000,000 shares authorized; 54,398,025 shares issued and outstanding at March 31, 2023, and 100,000,000 shares authorized; 54,282,132 shares issued and outstanding at March 31, 2022

 

 

54

 

 

 

54

 

 

 

%

 

Additional paid-in capital

 

 

229,631

 

 

 

227,127

 

 

1

 

%

 

Retained earnings

 

 

1,152,681

 

 

 

956,169

 

 

21

 

%

 

Accumulated other comprehensive loss

 

 

(43,049

)

 

 

(10,875

)

 

296

 

%

 

 

Total stockholders’ equity attributable to ServisFirst Bancshares, Inc.

 

 

1,339,317

 

 

 

1,172,475

 

 

14

 

%

 

Noncontrolling interest

 

 

500

 

 

 

500

 

 

 

%

 

 

Total stockholders’ equity

 

 

1,339,817

 

 

 

1,172,975

 

 

14

 

%

 

Total liabilities and stockholders’ equity

 

$

14,566,559

 

 

$

15,339,419

 

 

(5

)

%

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

 

 

 

(In thousands except per share data)

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

2023

 

2022

Interest income:

 

 

 

 

 

 

Interest and fees on loans

 

$

163,732

 

$

103,105

 

Taxable securities

 

 

10,895

 

 

8,223

 

Nontaxable securities

 

 

21

 

 

43

 

Federal funds sold

 

 

614

 

 

13

 

Other interest and dividends

 

 

6,060

 

 

1,804

 

Total interest income

 

 

181,322

 

 

113,188

 

Interest expense:

 

 

 

 

 

 

Deposits

 

 

55,713

 

 

5,843

 

Borrowed funds

 

 

17,308

 

 

1,623

 

Total interest expense

 

 

73,021

 

 

7,466

 

Net interest income

 

 

108,301

 

 

105,722

 

Provision for credit losses

 

 

4,197

 

 

5,362

 

Net interest income after provision for credit losses

 

 

104,104

 

 

100,360

 

Non-interest income:

 

 

 

 

 

 

Service charges on deposit accounts

 

 

1,934

 

 

2,142

 

Mortgage banking

 

 

442

 

 

526

 

Credit card income

 

 

1,689

 

 

2,372

 

Securities losses

 

 

 

 

(3,335

)

Increase in cash surrender value life insurance

 

 

1,621

 

 

1,608

 

Other operating income

 

 

635

 

 

4,635

 

Total non-interest income

 

 

6,321

 

 

7,948

 

Non-interest expense:

 

 

 

 

 

 

Salaries and employee benefits

 

 

19,066

 

 

18,301

 

Equipment and occupancy expense

 

 

3,435

 

 

2,933

 

Third party processing and other services

 

 

7,284

 

 

5,605

 

Professional services

 

 

1,654

 

 

992

 

FDIC and other regulatory assessments

 

 

1,517

 

 

1,132

 

Other real estate owned expense

 

 

6

 

 

3

 

Other operating expense

 

 

6,702

 

 

8,252

 

Total non-interest expense

 

 

39,664

 

 

37,218

 

Income before income tax

 

 

70,761

 

 

71,090

 

Provision for income tax

 

 

12,790

 

 

13,477

 

Net income

 

 

57,971

 

 

57,613

 

Net income available to common stockholders

 

$

57,971

 

$

57,613

 

Basic earnings per common share

 

$

1.07

 

$

1.06

 

Diluted earnings per common share

 

$

1.06

 

$

1.06

 

LOANS BY TYPE (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter 2023

 

4th Quarter 2022

 

3rd Quarter 2022

 

2nd Quarter 2022

 

1st Quarter 2022

Commercial, financial and agricultural

 

$

3,081,926

 

$

3,145,317

 

$

3,104,155

 

$

2,966,040

 

$

2,955,927

Real estate – construction

 

 

1,469,670

 

 

1,532,388

 

 

1,433,698

 

 

1,383,155

 

 

1,164,690

Real estate – mortgage:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Owner-occupied commercial

 

 

2,243,436

 

 

2,199,280

 

 

2,145,621

 

 

2,026,807

 

 

1,919,811

 

1-4 family mortgage

 

 

1,138,645

 

 

1,146,831

 

 

1,089,826

 

 

1,015,698

 

 

926,697

 

Other mortgage

 

 

3,624,071

 

 

3,597,750

 

 

3,438,762

 

 

3,160,510

 

 

2,869,158

Subtotal: Real estate – mortgage

 

 

7,006,152

 

 

6,943,861

 

 

6,674,209

 

 

6,203,015

 

 

5,715,666

Consumer

 

 

72,054

 

 

66,402

 

 

66,552

 

 

65,110

 

 

62,674

Total loans

 

$

11,629,802

 

$

11,687,968

 

$

11,278,614

 

$

10,617,320

 

$

9,898,957

SUMMARY OF CREDIT LOSS EXPERIENCE (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter 2023

 

4th Quarter 2022

 

3rd Quarter 2022

 

2nd Quarter 2022

 

1st Quarter 2022

Allowance for credit losses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning balance

 

$

146,297

 

 

$

140,967

 

 

$

128,387

 

 

$

119,463

 

 

$

116,660

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans charged off:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial financial and agricultural

 

 

1,257

 

 

 

2,116

 

 

 

2,902

 

 

 

1,667

 

 

 

2,574

 

 

Real estate – construction

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Real estate – mortgage

 

 

26

 

 

 

 

 

 

170

 

 

 

23

 

 

 

27

 

 

Consumer

 

 

390

 

 

 

200

 

 

 

261

 

 

 

123

 

 

 

75

 

 

 

Total charge offs

 

 

1,673

 

 

 

2,316

 

 

 

3,333

 

 

 

1,813

 

 

 

2,676

 

Recoveries:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial financial and agricultural

 

 

128

 

 

 

393

 

 

 

297

 

 

 

1,217

 

 

 

105

 

 

Real estate – construction

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Real estate – mortgage

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer

 

 

11

 

 

 

118

 

 

 

12

 

 

 

13

 

 

 

12

 

 

 

Total recoveries

 

 

143

 

 

 

511

 

 

 

309

 

 

 

1,230

 

 

 

117

 

 

Net charge-offs

 

 

1,530

 

 

 

1,805

 

 

 

3,024

 

 

 

583

 

 

 

2,559

 

 

Provision for credit losses

 

 

4,197

 

 

 

7,135

 

 

 

15,604

 

 

 

9,507

 

 

 

5,362

 

 

Ending balance

 

$

148,965

 

 

$

146,297

 

 

$

140,967

 

 

$

128,387

 

 

$

119,463

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for credit losses to total loans

 

 

1.28

%

 

 

1.25

%

 

 

1.25

%

 

 

1.21

%

 

 

1.21

%

 

Allowance for credit losses to total average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

loans

 

 

1.30

%

 

 

1.27

%

 

 

1.29

%

 

 

1.26

%

 

 

1.24

%

 

Net charge-offs to total average loans

0.05

%

 

 

0.06

%

 

 

0.11

%

 

 

0.02

%

 

 

0.11

%

 

Provision for credit losses to total average loans

 

 

0.14

%

 

 

0.25

%

 

 

0.57

%

 

 

0.37

%

 

 

0.23

%

 

Nonperforming assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonaccrual loans

 

$

13,157

 

 

$

12,450

 

 

$

11,655

 

 

$

10,540

 

 

$

14,738

 

 

 

Loans 90+ days past due and accruing

 

 

4,683

 

 

 

5,391

 

 

 

4,803

 

 

 

4,991

 

 

 

4,686

 

 

 

Other real estate owned and repossessed assets

 

 

248

 

 

 

248

 

 

 

1,245

 

 

 

1,207

 

 

 

1,989

 

 

Total

 

$

18,088

 

 

$

18,089

 

 

$

17,703

 

 

$

16,738

 

 

$

21,413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonperforming loans to total loans

 

 

0.15

%

 

 

0.15

%

 

 

0.15

%

 

 

0.15

%

 

 

0.20

%

 

Nonperforming assets to total assets

 

 

0.12

%

 

 

0.12

%

 

 

0.13

%

 

 

0.12

%

 

 

0.14

%

 

Nonperforming assets to earning assets

 

 

0.13

%

 

 

0.13

%

 

 

0.13

%

 

 

0.12

%

 

 

0.14

%

 

Allowance for credit losses to nonaccrual loans

1,132.24

%

 

 

1,175.08

%

 

 

1,209.50

%

 

 

1,218.05

%

 

 

826.19

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructured accruing loans

 

 

 

 

 

$

2,480

 

 

$

236

 

 

$

421

 

 

$

426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructured accruing loans to total loans

 

 

 

 

 

 

0.02

%

 

 

%

 

 

%

 

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TROUBLED DEBT RESTRUCTURINGS (TDRs) (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4th Quarter 2022

 

3rd Quarter 2022

 

2nd Quarter 2022

 

1st Quarter 2022

 

Beginning balance:

 

 

 

 

 

$

2,041

 

 

$

2,403

 

 

$

2,482

 

 

$

2,576

 

 

 

Additions

 

 

 

 

 

 

444

 

 

 

 

 

 

 

 

 

 

 

 

Net (paydowns) / advances

 

 

 

 

 

 

(5)

 

 

 

(362)

 

 

 

(79)

 

 

 

(94)

 

 

 

Charge-offs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transfer to OREO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance

 

 

 

 

 

$

2,480

 

 

$

2,041

 

 

$

2,403

 

 

$

2,482

 

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

 

 

 

 

 

 

 

 

 

(In thousands except per share data)

 

 

 

 

 

 

 

 

 

 

 

1st Quarter 2023

 

4th Quarter 2022

 

3rd Quarter 2022

 

2nd Quarter 2022

 

1st Quarter 2022

Interest income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest and fees on loans

 

$

163,732

 

$

153,924

 

$

131,375

 

$

111,287

 

 

$

103,105

 

Taxable securities

 

 

10,895

 

 

10,895

 

 

11,089

 

 

10,515

 

 

 

8,223

 

Nontaxable securities

 

 

21

 

 

27

 

 

30

 

 

37

 

 

 

43

 

Federal funds sold

 

 

614

 

 

818

 

 

632

 

 

93

 

 

 

13

 

Other interest and dividends

 

 

6,060

 

 

4,609

 

 

6,173

 

 

4,623

 

 

 

1,804

 

Total interest income

 

 

181,322

 

 

170,273

 

 

149,299

 

 

126,555

 

 

 

113,188

 

Interest expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

55,713

 

 

33,471

 

 

13,655

 

 

6,427

 

 

 

5,843

 

Borrowed funds

 

 

17,308

 

 

14,418

 

 

9,226

 

 

3,760

 

 

 

1,623

 

Total interest expense

 

 

73,021

 

 

47,889

 

 

22,881

 

 

10,187

 

 

 

7,466

 

Net interest income

 

 

108,301

 

 

122,384

 

 

126,418

 

 

116,368

 

 

 

105,722

 

Provision for credit losses

 

 

4,197

 

 

7,135

 

 

15,603

 

 

9,507

 

 

 

5,362

 

Net interest income after provision for credit losses

 

 

104,104

 

 

115,249

 

 

110,815

 

 

106,861

 

 

 

100,360

 

Non-interest income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service charges on deposit accounts

 

 

1,934

 

 

1,866

 

 

1,892

 

 

2,133

 

 

 

2,142

 

Mortgage banking

 

 

442

 

 

514

 

 

784

 

 

614

 

 

 

526

 

Credit card income

 

 

1,689

 

 

2,261

 

 

2,612

 

 

2,672

 

 

 

2,372

 

Securities losses

 

 

 

 

 

 

 

 

(2,833

)

 

 

(3,335

)

Increase in cash surrender value life insurance

 

 

1,621

 

 

1,600

 

 

1,637

 

 

1,633

 

 

 

1,608

 

Other operating income

 

 

635

 

 

725

 

 

2,014

 

 

5,287

 

 

 

4,635

 

Total non-interest income

 

 

6,321

 

 

6,966

 

 

8,939

 

 

9,506

 

 

 

7,948

 

Non-interest expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salaries and employee benefits

 

 

19,066

 

 

19,230

 

 

19,687

 

 

20,734

 

 

 

18,301

 

Equipment and occupancy expense

 

 

3,435

 

 

3,263

 

 

3,140

 

 

2,983

 

 

 

2,933

 

Third party processing and other services

 

 

7,284

 

 

8,170

 

 

7,213

 

 

6,345

 

 

 

5,605

 

Professional services

 

 

1,654

 

 

922

 

 

1,036

 

 

1,327

 

 

 

992

 

FDIC and other regulatory assessments

 

 

1,517

 

 

1,311

 

 

975

 

 

1,147

 

 

 

1,132

 

Other real estate owned expense

 

 

6

 

 

239

 

 

21

 

 

32

 

 

 

3

 

Other operating expense

 

 

6,702

 

 

4,957

 

 

10,613

 

 

7,253

 

 

 

8,252

 

Total non-interest expense

 

 

39,664

 

 

38,092

 

 

42,685

 

 

39,821

 

 

 

37,218

 

Income before income tax

 

 

70,761

 

 

84,123

 

 

77,069

 

 

76,546

 

 

 

71,090

 

Provision for income tax

 

 

12,790

 

 

16,399

 

 

13,038

 

 

14,410

 

 

 

13,477

 

Net income

 

 

57,971

 

 

67,724

 

 

64,031

 

 

62,136

 

 

 

57,613

 

Dividends on preferred stock

 

 

 

 

31

 

 

 

 

31

 

 

 

 

Net income available to common stockholders

 

$

57,971

 

$

67,693

 

$

64,031

 

$

62,105

 

 

$

57,613

 

Basic earnings per common share

 

$

1.07

 

$

1.25

 

$

1.18

 

$

1.14

 

 

$

1.06

 

Diluted earnings per common share

 

$

1.06

 

$

1.24

 

$

1.17

 

$

1.14

 

 

$

1.06

 

AVERAGE BALANCE SHEETS AND NET INTEREST ANALYSIS (UNAUDITED)

ON A FULLY TAXABLE-EQUIVALENT BASIS

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter 2023

 

4th Quarter 2022

 

3rd Quarter 2022

 

2nd Quarter 2022

 

1st Quarter 2022

 

 

 

 

 

Average Balance

 

Yield / Rate

 

Average Balance

 

Yield / Rate

 

Average Balance

 

Yield / Rate

 

Average Balance

 

Yield / Rate

 

Average Balance

 

Yield / Rate

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-earning assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans, net of unearned income (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Taxable

 

$

11,632,439

 

5.70

%

 

$

11,465,538

 

5.32

%

 

$

10,900,105

 

4.77

%

 

$

10,165,470

 

4.38

%

 

$

9,621,484

 

4.29

%

 

 

Tax-exempt (2)

 

 

18,978

 

3.36

 

 

 

19,526

 

6.60

 

 

 

19,852

 

4.14

 

 

 

23,616

 

4.09

 

 

 

25,195

 

4.08

 

 

 

 

Total loans, net of unearned income

 

 

11,651,417

 

5.70

 

 

 

11,485,064

 

5.32

 

 

 

10,919,957

 

4.77

 

 

 

10,189,086

 

4.38

 

 

 

9,646,679

 

4.29

 

 

Mortgage loans held for sale

 

 

1,522

 

6.40

 

 

 

1,515

 

3.67

 

 

 

2,906

 

2.73

 

 

 

471

 

3.41

 

 

 

927

 

1.73

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Taxable

 

 

1,724,523

 

2.54

 

 

 

1,755,764

 

2.49

 

 

 

1,797,560

 

2.47

 

 

 

1,775,425

 

2.37

 

 

 

1,518,572

 

2.17

 

 

 

Tax-exempt (2)

 

 

3,781

 

2.43

 

 

 

4,863

 

2.39

 

 

 

5,863

 

2.39

 

 

 

7,148

 

2.35

 

 

 

8,812

 

2.36

 

 

 

 

Total securities (3)

 

 

1,728,304

 

2.54

 

 

 

1,760,627

 

2.49

 

 

 

1,803,423

 

2.47

 

 

 

1,782,573

 

2.37

 

 

 

1,527,384

 

2.17

 

 

Federal funds sold

 

 

50,526

 

4.93

 

 

 

82,656

 

3.93

 

 

 

102,028

 

2.46

 

 

 

30,721

 

1.21

 

 

 

16,639

 

0.31

 

 

Restricted equity securities

 

 

9,919

 

7.69

 

 

 

7,724

 

7.35

 

 

 

7,724

 

3.65

 

 

 

7,724

 

3.74

 

 

 

7,371

 

3.70

 

 

Interest-bearing balances with banks

 

 

510,021

 

4.67

 

 

 

458,115

 

3.83

 

 

 

945,142

 

2.56

 

 

 

2,332,412

 

0.80

 

 

 

3,637,882

 

0.20

 

 

Total interest-earning assets

 

$

13,951,709

 

5.27

 

 

$

13,795,701

 

4.90

 

 

$

13,781,180

 

4.30

 

 

$

14,342,987

 

3.54

 

 

$

14,836,882

 

3.06

 

Non-interest-earning assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and due from banks

 

 

106,448

 

 

 

 

 

113,823

 

 

 

 

 

256,607

 

 

 

 

 

204,994

 

 

 

 

 

74,534

 

 

 

 

Net premises and equipment

 

 

60,617

 

 

 

 

 

60,323

 

 

 

 

 

60,155

 

 

 

 

 

60,673

 

 

 

 

 

61,209

 

 

 

 

Allowance for credit losses, accrued interest and other assets

 

 

279,775

 

 

 

 

 

273,964

 

 

 

 

 

294,006

 

 

 

 

 

297,893

 

 

 

 

 

313,560

 

 

 

 

 

 

Total assets

 

$

14,398,549

 

 

 

 

$

14,243,811

 

 

 

 

$

14,391,948

 

 

 

 

$

14,906,547

 

 

 

 

$

15,286,185

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing deposits:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Checking

 

$

1,675,355

 

1.25

%

 

$

1,763,622

 

0.73

%

 

$

1,722,926

 

0.28

%

 

$

1,699,602

 

0.21

%

 

$

1,594,645

 

0.20

%

 

Savings

 

 

134,671

 

0.94

 

 

 

141,163

 

0.64

 

 

 

144,368

 

0.21

 

 

 

134,469

 

0.18

 

 

 

135,545

 

0.17

 

 

Money market

 

 

5,756,642

 

3.17

 

 

 

5,047,133

 

2.07

 

 

 

4,444,583

 

0.89

 

 

 

4,617,021

 

0.33

 

 

 

4,985,224

 

0.26

 

 

Time deposits

 

 

850,639

 

2.51

 

 

 

860,336

 

1.69

 

 

 

809,057

 

1.16

 

 

 

766,225

 

0.86

 

 

 

792,930

 

0.91

 

 

 

Total interest-bearing deposits

 

 

8,417,307

 

2.68

 

 

 

7,812,254

 

1.70

 

 

 

7,120,934

 

0.76

 

 

 

7,217,317

 

0.36

 

 

 

7,508,344

 

0.31

 

 

Federal funds purchased

 

 

1,389,217

 

4.67

 

 

 

1,453,445

 

3.75

 

 

 

1,493,444

 

2.27

 

 

 

1,550,805

 

0.79

 

 

 

1,620,012

 

0.23

 

 

Other borrowings

 

 

114,726

 

4.61

 

 

 

64,726

 

4.23

 

 

 

65,406

 

4.19

 

 

 

64,713

 

4.28

 

 

 

64,708

 

4.28

 

 

Total interest-bearing liabilities

 

$

9,921,250

 

2.98

%

 

$

9,330,425

 

2.04

%

 

$

8,679,784

 

1.05

%

 

$

8,832,835

 

0.46

%

 

$

9,193,064

 

0.33

%

Non-interest-bearing liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-interest-bearing demand deposits

 

 

3,086,774

 

 

 

 

 

3,572,956

 

 

 

 

 

4,410,318

 

 

 

 

 

4,824,521

 

 

 

 

 

4,870,701

 

 

 

 

Other liabilities

 

 

72,121

 

 

 

 

 

77,544

 

 

 

 

 

62,093

 

 

 

 

 

58,784

 

 

 

 

 

59,619

 

 

 

 

Stockholders’ equity

 

 

1,358,587

 

 

 

 

 

1,307,553

 

 

 

 

 

1,263,870

 

 

 

 

 

1,205,551

 

 

 

 

 

1,156,186

 

 

 

 

Accumulated other comprehensive (loss) income

 

 

(40,183)

 

 

 

 

 

(44,667)

 

 

 

 

 

(24,117)

 

 

 

 

 

(15,144)

 

 

 

 

 

6,615

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

14,398,549

 

 

 

 

$

14,243,811

 

 

 

 

$

14,391,948

 

 

 

 

$

14,906,547

 

 

 

 

$

15,286,185

 

 

 

Net interest spread

 

 

 

 

2.29

%

 

 

 

 

2.86

%

 

 

 

 

3.25

%

 

 

 

 

3.08

%

 

 

 

 

2.77

%

Net interest margin

 

 

 

 

3.15

%

 

 

 

 

3.52

%

 

 

 

 

3.64

%

 

 

 

 

3.26

%

 

 

 

 

2.89

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Average loans include nonaccrual loans in all periods. Loan fees of $3,263, $3,630, $3,849, $5,303, and $6,823 are included in interest income in the first quarter of 2023, fourth quarter of 2022, third quarter of 2022, second quarter of 2022, and first quarter of 2022, respectively.

(2)

Interest income and yields are presented on a fully taxable equivalent basis using a tax rate of 21%.

(3)

Unrealized (losses) gains on debt securities of $(59,738), $(62,568), $(34,688), $(25,703), and $8,245 for the first quarter of 2023, fourth quarter of 2022, third quarter of 2022, second quarter of 2022, and first quarter of 2022, respectively, are excluded from the yield calculation.

 

ServisFirst Bank

Davis Mange (205) 949-3420

[email protected]

KEYWORDS: Alabama United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

AVANGRID Reports Strong Progress on Ambitious ESG+F Goals and Reinforces Its Commitment to Climate Action

AVANGRID Reports Strong Progress on Ambitious ESG+F Goals and Reinforces Its Commitment to Climate Action

Releases its 2022 Sustainability Report, sharing that it met or exceeded 85% of the company’s 2022 Environmental, Social, Governance and Financial Stewardship goals

Among its many achievements is operating 8.7 GW of emissions-free installed capacity, enough to power more than 2.8 million homes, and progressing toward Scopes 1 and 2 carbon neutrality by 2030

ORANGE, Conn.–(BUSINESS WIRE)–
AVANGRID, Inc. (NYSE: AGR), a leading sustainable energy company and member of the Iberdrola Group, today released its 2022 Sustainability Report, titled “Investing in a Clean Energy Future for All,” which details that the company met or exceeded 85% of its 2022 Environmental, Social, Governance and Financial Stewardship (ESG+F) goals. The report also indicated AVANGRID is on track to meet its ambitious long-term ESG+F goals by demonstrating clear progress and actions underway to support their achievement. This includes AVANGRID’s industry-leading 2030 carbon neutrality targets for scopes 1 and 2and its commitment to reach 16.9 GW emissions-free installed capacity by 2030.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230417005829/en/

AVANGRID's 2022 Impact at a Glance. (Graphic: Business Wire)

AVANGRID’s 2022 Impact at a Glance. (Graphic: Business Wire)

“With 91% emissions-free generation and an emissions intensity over six times lower than the U.S. utility average, AVANGRID demonstrates true clean energy leadership,” said Pedro Azagra, CEO of AVANGRID. “We set the bar high and continue to raise it with comprehensive commitments across all aspects of ESG+F, as you’ll see demonstrated throughout our 2022 Sustainability Report. Our strong track record of ESG+F execution ensures that we, along with the Iberdrola Group, are a critical and strategic leader in advancing the transition to a clean and sustainable future.”

The company’s annual Sustainability Report tracks and highlights AVANGRID’s sustainability results towards its ESG+F commitments and how these actions are creating a clean energy future. The company’s ESG+F goals include but are not limited to: Scopes 1 and 2 carbon neutrality (by 2030), increasing emissions-free installed capacity by 190% compared to 2015 (by 2030), increasing supplier diversity spend to $300 million (in 2025) and reaching 35,000 employee volunteer hours (in 2025).

Among the 2022 successes highlighted in the report, AVANGRID achieved:

  • 8.7 GW installed emissions-free capacity.

  • 35% of women in executive positions, reaching its aspirational goal set for 2025 three years early.

  • 28% reduction in CO2 emissions intensity (compared to 2015).

  • Sustaining a leadership position as the third-largest green, social and sustainability bonds issuer in the U.S.

  • 10,464 employee volunteer hours, well surpassing its 2022 goal of 7,000 hours.

  • $195 million spent with diverse suppliers and 67% of our suppliers met our sustainability standards.

  • 42,000 hours of cybersecurity training and a 50% reduction in phishing click rate, putting the company ahead of its 2025 goal.

  • Recognition by third parties as a leader in ethics, including being named one of the World’s Most Ethical Companies by Ethisphere for a fifth consecutive year.

“At AVANGRID, we make a commitment and then we take action,” said Laney Brown, Vice President of Sustainability at AVANGRID. “Across the board, we are making excellent progress on our ESG+F goals and commitments. We’re demonstrating that clean energy is not just a beneficial outcome for the environment and society, but an opportunity to help people and communities participate in the clean energy transition through new jobs, and for leading companies like ours to make critical and strategic investments.”

A full list of AVANGRID’s ESG+F goals and its 2022 achievements can be found in the 2022 Sustainability Report here.

About AVANGRID: AVANGRID, Inc. (NYSE: AGR) aspires to be the leading sustainable energy company in the United States. Headquartered in Orange, CT with approximately $41 billion in assets and operations in 24 U.S. states, AVANGRID has two primary lines of business: networks and renewables. Through its networks business, AVANGRID owns and operates eight electric and natural gas utilities, serving more than 3.3 million customers in New York and New England. Through its renewables business, AVANGRID owns and operates a portfolio of renewable energy generation facilities across the United States. AVANGRID employs more than 7,500 people and has been recognized by JUST Capital in 2021, 2022 and 2023 as one of the JUST 100 companies – a ranking of America’s best corporate citizens. In 2023, AVANGRID ranked first within the utility sector for its commitment to the environment. The company supports the U.N.’s Sustainable Development Goals and was named among the World’s Most Ethical Companies in 2023 for the fifth consecutive year by the Ethisphere Institute. AVANGRID is a member of the group of companies controlled by Iberdrola, S.A. For more information, visit www.avangrid.com.

Forward Looking Statements

Certain statements in this release may relate to our future business and financial performance and future events or developments involving us and our subsidiaries that are not purely historical and may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as “may,” “will,” “should,” “would,” “could,” “can,” “expect(s),” “believe(s),” “anticipate(s),” “intend(s),” “plan(s),” “estimate(s),” “project(s),” “assume(s),” “guide(s),” “target(s),”“forecast(s),” “are (is) confident that” and “seek(s)” or the negative of such terms or other variations on such terms or comparable terminology. Such forward-looking statements include, but are not limited to, statements about our plans, objectives and intentions, outlooks or expectations for earnings, revenues, expenses or other future financial or business performance, strategies or expectations, or the impact of legal or regulatory matters on business, results of operations or financial condition of the business and other statements that are not historical facts. Such statements are based upon the current reasonable beliefs, expectations, and assumptions of our management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially. Important factors are discussed and should be reviewed in our Form 10-K and other subsequent filings with the SEC. Specifically, forward-looking statements include, without limitation:

  • our ability to close the proposed merger with PNMR, the anticipated timing and terms of the proposed merger, our ability to realize the anticipated benefits of the proposed merger and our ability to manage the risks of the proposed merger;
  • future financial performance, anticipated liquidity and capital expenditures;
  • actions or inactions of local, state or federal regulatory agencies;
  • adverse publicity or other reputational harm; and
  • other presently unknown unforeseen factors.

Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may vary in material respects from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements to reflect events or circumstances after the date of this report, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Other risk factors are detailed from time to time in our reports filed with the SEC, and we encourage you to consult such disclosures.

MEDIA:

Sarah Warren

[email protected]

585-794-9253

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Environment Technology Security Utilities Oil/Gas Professional Services Sustainability Alternative Energy Energy Environmental, Social and Governance (ESG)

MEDIA:

Logo
Logo
Photo
Photo
AVANGRID’s 2022 Impact at a Glance. (Graphic: Business Wire)